Literature DB >> 343588

Pulmonary disease caused by Candida species.

H Masur, P P Rosen, D Armstrong.   

Abstract

Candida species are often found in sputum specimens. Their role as a possible cause of pulmonary disease is a frequent consideration, particularly in patients receiving immunosuppressive or long-standing antimicrobial therapy. At Memorial Hospital and New York Hospital, 30 patients with histologic evidence of Candida pulmonary infection were identified over a two year period. These infections reached the lungs by hematogenous spread in 10 patients and by aspiration in 16 patients. Most the patients had malignant neoplastic disease. The Candida pulmonary disease appeared to be significant clinical factor in only three cases. Experience from our institutions and from the literature indicates that Candida species rarely cause significant pulmonary disease. When such involvement is extensive, the patient is usually terminally ill from multiple other factors.

Entities:  

Mesh:

Year:  1977        PMID: 343588     DOI: 10.1016/0002-9343(77)90546-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Candida pneumonia: experience with 20 patients.

Authors:  Z Mohsenifar; S K Chopra; B L Johnson; D H Simmons
Journal:  West J Med       Date:  1979-09

Review 2.  Immunologic tests in the diagnosis of pulmonary infection.

Authors:  E Goldstein; J Koo
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

3.  Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR.

Authors:  David N Fredricks; Caitlin Smith; Amalia Meier
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Isolation of opportunistic fungi from bronchoalveolar lavage of compromised hosts in Isfahan, Iran.

Authors:  S Shadzi; M Chadeganipour
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Candida lung abscesses complicating parenteral nutrition.

Authors:  B R O'Driscoll; R D Cooke; H Mamtora; M H Irving; A Bernstein
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

Review 6.  Laboratory diagnosis of invasive candidiasis.

Authors:  J M Jones
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 7.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

8.  Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components.

Authors:  M Castro; N V Ralston; T I Morgenthaler; M S Rohrbach; A H Limper
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 9.  Invasive candidiasis in pediatric intensive care units.

Authors:  Sunit Singhi; Akash Deep
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

10.  Practices in non-neutropenic ICU patients with Candida-positive airway specimens.

Authors:  Elie Azoulay; Yves Cohen; Jean-Ralph Zahar; Maité Garrouste-Orgeas; Christophe Adrie; Pierre Moine; Arnaud de Lassence; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.